Detalhe da pesquisa
1.
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial.
Hematol Oncol
; 41(3): 415-423, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36534947
2.
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.
Haematologica
; 102(11): 1931-1935, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28775121
3.
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies.
Leuk Lymphoma
; 65(4): 460-471, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38164812
4.
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial.
J Clin Oncol
; 38(33): 3905-3913, 2020 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32946355
5.
The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET-2-adapted HD0607 trial.
Cancer Med
; 9(23): 8735-8746, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33155754
6.
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial.
J Clin Oncol
; 36(5): 454-462, 2018 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29360414
7.
Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma.
Oncotarget
; 8(53): 91703-91710, 2017 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29207679